Infection Risk Management Services

Target Infection. Focus on Prevention. 

• 50% of SSIs and BSIs account for more than half of the total annual costs associated with the most common HAIs¹* 
• Due to pay-for-performance programs under the ACA†, infections put over 6% of a facility’s inpatient Medicare reimbursement at risk^2,3 
• The Joint Commission's National Patient Safety Goals 07.04.01 and 07.05.01 assess a facility's evidence-based policies and practices aimed at reducing the risk of BSIs and SSIs⁴

Attributes 

• Clinical experts conduct confidential analyses of current clinical practices to help identify potential risks for SSIs and BSIs in your facility 
• Customized plans to help healthcare providers implement evidence-based infection prevention strategies utilizing JJMDC devices and drive compliance with facility policies 
• Educational resources designed to engage patients in their care from pre-admission through discharge 

Benefits 

• Address risk factors for costly infections through the appropriate utilization of JJMDC devices 
• Reduce variation in clinical practices and purchasing patterns 
• Enhance engagement of patients and staff throughout an episode of care  

Needs Identification

1. Your team shares your infection risk management goals with the Johnson & Johnson Medical Devices Companies (JJMDC) 
2. Together, your team and JJMDC define areas to assess for potential gaps in infection prevention practices that can be addressed by the appropriate utilization of JJMDC devices 
3. JJMDC clinical nurse specialist conducts a confidential, on-site analysis of current practices in your facility 
4. Based on assessment findings, JJMDC provides tailored recommendations to address infection risks 
5. Your team and JJMDC agree on training and education plans to address top needs, and establish metrics to track progress